Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bio-SCAN: A CRISPR/dCas9-Based Lateral Flow Assay for Rapid, Specific, and Sensitive Detection of SARS-CoV-2

23 Dec 2021

Abstract excerpt

Simple, rapid, specific, and sensitive point-of-care detection methods are needed to contain the spread of SARS-CoV-2. CRISPR/Cas9-based lateral flow assays are emerging as a powerful alternative for COVID-19 diagnostics. Here, we developed Bio-SCAN (biotin-coupled specific CRISPR-based assay for nucleic acid detection) as an accurate pathogen detection platform that requires no sophisticated equipment or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced biosensing and bioanalysis techniques
Share to CRISPR and Genetic Engineering
Share to SARS-CoV-2 detection and testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34939798
DOI: 10.1021/acssynbio.1c00499

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bio-SCAN: A CRISPR/dCas9-Based Lateral Flow Assay for Rapid, Specific, and Sensitive Detection of SARS-CoV-2PMID 34939798Read ↗

CRISPR/Cas9-Based Lateral Flow and Fluorescence DiagnosticsSemantic proximity Read ↗

Virus detection by CRISPR-Cas9-mediated strand displacement in a lateral flow assaySemantic proximity Read ↗

Digital CRISPR/Cas‐Assisted Assay for Rapid and Sensitive Detection of SARS‐CoV‐2Semantic proximity Read ↗

Simultaneous Dual‐Gene Diagnosis of SARS‐CoV‐2 Based on CRISPR/Cas9‐Mediated Lateral Flow AssaySemantic proximity Read ↗

CRISPR-cas13 enzymology rapidly detects SARS-CoV-2 fragments in a clinical settingSemantic proximity Read ↗

SARS-CoV-2 detection with CRISPR diagnosticsSemantic proximity Read ↗

A Multiplexed Cas13-Based Assay with Point-of-Care Attributes for Simultaneous COVID-19 Diagnosis and Variant SurveillanceSemantic proximity Read ↗

Simultaneous Dual‐Gene Diagnosis of SARS‐CoV‐2 Based on CRISPR/Cas9‐Mediated Lateral Flow AssaySemantic proximity Read ↗

Multiplexable and Biocomputational Virus Detection by CRISPR-Cas9-Mediated Strand DisplacementSemantic proximity Read ↗

CRISPR-based biosensing systems: a way to rapidly diagnose COVID-19Semantic proximity Read ↗

Clinical validation of engineered CRISPR/Cas12a for rapid SARS-CoV-2 detectionSemantic proximity Read ↗

Highly sensitive and rapid detection of SARS‐CoV‐2 via a portable CRISPR‐Cas13a‐based lateral flow assaySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.